News

Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free Economic Zone (IFEZ), a specially-designated economic zone in the city of Incheon. The new site is approximately...

AbbVie announced that the EC has approved Rinvoq (upadacitinib, 15 mg), an oral, once daily selective and reversible JAK inhibitor for the treatment of active psoriatic arthritis (PsA) in adult patients who have responded inadequately to, or who are...

The Serum Institute of India (SII) will supply Saudi Arabia with 3 million AstraZeneca COVID-19 vaccine doses priced at $5.25 each in about a week on behalf of the British drugmaker. SII has no immediate plans, however, to divert supplies...

MedPharm Ltd, the world’s leading contract service provider of contract topical and transdermal product design and formulation development services, has launched its Scientific Advisory Committee, headed by company founder and Board member, Professor Marc Brown. Marc Brown has served...

Roche announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement (GBP) with Sysmex. Under this new framework, the parties renewed their commitment to the long standing distribution, sales and service (DSS) agreement, allowing Roche to...

AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) (including small lymphocytic lymphoma ). The approval by the Japanese...

Care Access Research, a decentralized research organization (DRO) that connects physicians and research experts, entered a collaboration with AstraZeneca to accelerate a clinical trial in the U.S. for AZD7442, AstraZeneca’s long-acting monoclonal antibody (LAAB) combination for the potential prevention...